Skip to main content
Godavari Drugs Ltd. logo

Godavari Drugs Ltd. — Investor Relations & Filings

Ticker · 530317 ISIN · INE362C01012 LEI · 254900ASHPUQ97FS9O52 BSE.NS Manufacturing
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS 530317

About Godavari Drugs Ltd.

http://godavaridrugs.com/

Godavari Drugs Ltd. is a manufacturer of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company specializes in the production of bulk drugs, with a significant focus on the sulfa drug segment. Its core product portfolio includes Sulfamethoxazole, Trimethoprim, and various chemical intermediates used in the synthesis of therapeutic agents. The company operates manufacturing facilities equipped for complex chemical processes, adhering to international quality standards and Good Manufacturing Practices (GMP). Godavari Drugs Ltd. serves both domestic and international markets, providing essential components for antibiotic formulations and other medicinal applications. The organization emphasizes process optimization and chemical research to maintain its position as a reliable supplier in the global pharmaceutical supply chain.

Recent filings

Filing Released Lang Actions
Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the financial results for the ....
Regulatory Filings Classification · 75% confidence The document is an intimation under SEBI LODR Regulation 29 regarding an upcoming Board meeting to consider and approve the audited financial results. It is a regulatory announcement/notice rather than the financial results themselves or an AGM presentation. It does not announce management changes, dividends, or attach a report, so it falls under general regulatory filings. Therefore, it is classified as Regulatory Filings (RNS).
2026-05-22 English
Annual Secretarial Compliance Report for the year ended 31st March, 2026
Regulatory Filings Classification · 90% confidence The document is a letter to the stock exchange enclosing the Annual Secretarial Compliance Report under SEBI LODR Regulation 24A for the year ended March 31, 2026. It is a statutory compliance certificate prepared by company secretaries, not a financial statement (10-K/IR) or earnings release, nor an AGM presentation or proxy solicitation. It does not announce board changes, dividends, or capital actions. It is filed to meet regulatory disclosure requirements, fitting the fallback “Regulatory Filings” category.
2026-05-20 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.